αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/ISCO

ISCO

ISCO Institutional Ownership & 13F Filings

International Stem Cell CORP

+$0.0

Net Activity

Data as of: 2023-03-31

Institutions Holding

1

Popularity Rank

#21975

Avg Weight

0.00%

Total Value

$4.0

Ownership Trend

1 institutions currently hold ISCO, with 0 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2023)

Neutral

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

0

Key Holders

Key Holders

Top 5 by Value

AW
Accel Wealth Management
$4.0

Top 5 by Conviction

AW
Accel Wealth Management
0.00%
View all 1 holding institutions

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$0.0

Total Sell Value

New buy0
Trim0
Add0
Sold out0

0

Net Buyers

0

Net Sellers

Smart Money Convergence

ISCO does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2023-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/ISCO

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

International Stem Cell Corp (ISCO) has agreed to sell its wholly owned subsidiary Lifeline Cell Technology to the American Type Culture Collection (ATCC) for a base purchase price of $25 million, subject to adjustments for working capital and other items. The deal is expected to close in the third quarter of 2026. Lifeline Cell Technology develops and sells biological materials for scientific research, including primary human cells, stem cells, and cell culture media.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

460378201

FAQ

Who are the top institutional investors holding INTERNATIONAL STEM CELL CORP (ISCO)?
Major stakeholders currently include Accel Wealth Management ($4.0). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in ISCO.
What is the overall institutional sentiment toward ISCO recently?
Institutional sentiment appears Neutral. During the most recent reporting quarter, the stock experienced no significant net capital flow from tracked managers.
Which institutions have been selling or reducing their ISCO positions?
In the latest period, no tracked funds trimmed or exited their positions in ISCO.
Are there any notable investors adding ISCO to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in ISCO during the last reporting period.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access ISCO's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/ISCO

CLI

npx alphasmo stocks get ISCO
Full API & MCP documentation →